PARD3 and hepatocellular carcinoma: To screen a biomarker closely related to the formation and progression of HCC, we analyzed the differential expression of PARD3 and its clinicopathological relevance, using liver hepatocellular carcinoma (LIHC) RNA sequencing (RNA-seq) data of HCC patients from The Cancer Genome Atlas (TCGA).